We are live on ! Find out more
WST icon

West Pharmaceutical
WST

197 hedge funds and large institutions have $2.19B invested in West Pharmaceutical in 2013 Q2 according to their latest regulatory filings, with 197 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

180.46% more ownership

Funds ownership: 0% → 180.46% (+180%)

Holders
197
Holders Change
+197
Holders Change %
–
% of All Funds
6.43%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.23%
New
197
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GIA
126
GHP Investment Advisors
Colorado
$957K +$896K +27,232 New
CCG
127
Chatham Capital Group
Georgia
$898K +$841K +25,550 New
BNP Paribas Financial Markets
128
BNP Paribas Financial Markets
France
$847K +$793K +24,108 New
WTNA
129
Wilmington Trust National Association
Delaware
$833K +$781K +23,718 New
UBS AM
130
UBS AM
Illinois
$822K +$770K +23,398 New
Bank of Montreal
131
Bank of Montreal
Ontario, Canada
$821K +$769K +23,382 New
Jennison Associates
132
Jennison Associates
New York
$786K +$736K +22,366 New
SIM
133
Spark Investment Management
New York
$730K +$684K +20,800 New
First Trust Advisors
134
First Trust Advisors
Illinois
$675K +$633K +19,228 New
ANTB
135
AMG National Trust Bank
Colorado
$603K +$565K +17,164 New
PA
136
Profund Advisors
Maryland
$594K +$557K +16,920 New
ACI
137
AMP Capital Investors
Australia
$556K +$521K +15,818 New
MCM
138
Manchester Capital Management
Vermont
$554K +$519K +15,760 New
M&T Bank
139
M&T Bank
New York
$544K +$510K +15,490 New
ST
140
Smithfield Trust
Pennsylvania
$538K +$504K +15,308 New
BIM
141
BRC Investment Management
Colorado
$523K +$490K +14,888 New
RA
142
Royce & Associates
New York
$513K +$480K +14,600 New
CG
143
Colony Group
Massachusetts
$507K +$476K +14,456 New
CB
144
Commerce Bank
Missouri
$505K +$473K +14,380 New
AQR Capital Management
145
AQR Capital Management
Connecticut
$499K +$468K +14,216 New
PNC Financial Services Group
146
PNC Financial Services Group
Pennsylvania
$481K +$451K +13,700 New
BG
147
Bahl & Gaynor
Ohio
$474K +$444K +13,500 New
MLM
148
Mount Lucas Management
Pennsylvania
$464K +$435K +13,210 New
PI
149
Placemark Investments
Illinois
$461K +$434K +13,184 New
VAM
150
Visium Asset Management
New York
$442K +$414K +12,568 New
4 5
6
7 8

WST Hedge Fund Activity: Q2 2013 in Review

197 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2013, worth a combined $2.19B.

Buyers outnumbered sellers: 197 funds opened new WST positions and 0 closed out — a net gain of 197 holders — while 0 added to existing stakes and 0 trimmed.

  • 197 institutional investors held West Pharmaceutical (WST) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.19B of West Pharmaceutical stock for Q2 2013.
  • 197 funds opened new West Pharmaceutical positions in Q2 2013 and 0 closed out, a net change of +197 holders.

Based on aggregated 13F filings for Q2 2013.